We are using too many PPIs, and we need to stop: A European perspective

American Journal of Gastroenterology

Volumn 111, Issue 8, 2016, Pages 1085-1086

  Lanas, Angel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GENERIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR;

CLINICAL PRACTICE; DRUG COST; DRUG INDICATION; DRUG INDUSTRY; DRUG MISUSE; DRUG USE; EUROPEAN; GASTROESOPHAGEAL REFLUX; HUMAN; INAPPROPRIATE PRESCRIBING; PEPTIC ULCER; POTENTIALLY INAPPROPRIATE MEDICATION; PRIORITY JOURNAL; PROPHYLAXIS; SHORT SURVEY; STOMACH DISEASE; STOMACH INJURY; STRESS ULCER; CHEMICALLY INDUCED; EUROPE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EUROPE; GASTROESOPHAGEAL REFLUX; HUMANS; PEPTIC ULCER; PRACTICE PATTERNS, PHYSICIANS'; PROTON PUMP INHIBITORS;

EID: 84966522066     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.166     Document Type: Short Survey

References (3)

1. http://stats.oecd.org/Index.aspx?DataSetCode=HEALTH-PHMC: accessed on 14 February 2016.
2. van Vliet EP, Otten HJ, Rudolphus A, et al. Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards. Eur J Gastroenterol Hepatol 2008; 20: 608-12.
3. McDonald EG, Jones J, Green L, et al. Reduction of inappropriate exit prescriptions for proton pump inhibitors: a before-After study using education paired with a web-based quality-improvement tool. J Hosp Med 2015; 10: 281-6.